Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter

Par Health recalls two lots of Brevital Sodium injection due to particulate matter

Par Health is voluntarily recalling two lots of Brevital Sodium 500 mg/vial (Methohexital Sodium for Injection, USP) to the hospital level due to the presence of cellulose particulate matter. The recall was announced October 8, 2026.